Arcutis Biotherapeutics, Inc. (ARQT) ownership: insiders 2% · institutions 106% (13F 2026-03-31). Insider activity, 90 days: Routine (11 sales, 0 open-market buys). 6 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 12327000.00 | $290.42M | 9.8% | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 9874511.00 | $232.64M | 7.9% | 2026-03-31 |
| BlackRock | 9200411.00 | $216.76M | 7.3% | 2026-03-31 |
| Rubric Capital Management LP | 8271577.00 | $194.88M | 6.6% | 2026-03-31 |
| Vanguard | 7750935.00 | $182.61M | 6.2% | 2026-03-31 |
| State Street | 6296197.00 | $148.34M | 5.0% | 2026-03-31 |
| Polar Capital Holdings Plc | 5666940.00 | $133.51M | 4.5% | 2026-03-31 |
| Jennison Associates LLC | 4980770.00 | $117.35M | 4.0% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-19 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 |
Back to ARQT overview · ARQT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.